Quarterly report pursuant to Section 13 or 15(d)

Comparison of Restated Financial Statements to Financial Statements as Previously Reported (Details 2)

v3.20.4
Comparison of Restated Financial Statements to Financial Statements as Previously Reported (Details 2) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities:        
Net (loss) income $ (3,349,343) $ (21,790) $ (9,003,142) $ 198,975
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Interest income earned on investments held in Trust Account     (38,704) (1,203,538)
Stock-based compensation     2,625,000
Amortization on debt discount     1,705,889
Loss on issuance of convertible promissory notes     1,657,522
Change in fair value of the derivative liability and accrued issuable equity 15,972 15,972
Changes in operating assets and liabilities:        
Prepaid expenses     9,125 (35,840)
Accounts payable and accrued expenses    
Net cash and restricted cash used in operating activities     (1,141,614) (1,160,205)
Cash Flows from Investing Activities:        
Cash withdrawn from Trust Account for redemptions     1,889,579 69,305,537
Investment of cash in Trust Account     (276,448) (431,164)
Net cash and restricted cash provided by investing activities     1,613,131 69,271,258
Cash Flows from Financing Activities:        
Advances from 180     942,870
Proceeds from loans payable     2,750,000
Repayment of advances from 180     (1,156,664)
Proceeds from convertible promissory note - related party     33,877
Repayment of convertible promissory note - related party     (112,922) (80,000)
Proceeds from convertible promissory notes     10,000
Redemptions of common stock     (1,889,579) (69,305,537)
Net cash and restricted cash used in financing activities     (365,288) (67,545,903)
Net Change in Cash and Restricted Cash     106,229  
Cash and Restricted Cash - Beginning of period     546,636 270,884
Cash and Restricted Cash - Ending of period 652,865 $ 836,034 652,865 836,034
Non-cash investing and financing activities:        
Change in value of common stock subject to possible redemption     1,542,473 198,973
Waiver of deferred underwriting fee     4,025,000
Initial classification of derivative liability in connection with issuance of convertible promissory note     275,847
Original issue discount in connection with issuance of convertible promissory note     305,556
Accrual of debt issue costs     416,692
Issuance of commitment shares and leak out shares in connection with convertible promissory notes     4,059,904
As Originally Reported [Member]        
Cash Flows from Operating Activities:        
Net (loss) income (1,884,446)   (4,413,245)  
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Interest income earned on investments held in Trust Account     (38,704)  
Stock-based compensation      
Amortization on debt discount     1,658,866  
Loss on issuance of convertible promissory notes     1,657,522  
Change in fair value of the derivative liability and accrued issuable equity (19,177)   (19,177)  
Changes in operating assets and liabilities:        
Prepaid expenses     9,125  
Accounts payable and accrued expenses     89,845  
Net cash and restricted cash used in operating activities     (1,055,768)  
Cash Flows from Investing Activities:        
Cash withdrawn from Trust Account for redemptions     1,889,579  
Investment of cash in Trust Account     (276,448)  
Net cash and restricted cash provided by investing activities     1,613,131  
Cash Flows from Financing Activities:        
Advances from 180     9,990  
Proceeds from loans payable      
Repayment of advances from 180     (1,042,500)  
Proceeds from convertible promissory note - related party     33,877  
Repayment of convertible promissory note - related party     (312,922)  
Proceeds from convertible promissory notes     2,750,000  
Redemptions of common stock     (1,889,579)  
Net cash and restricted cash used in financing activities     (451,134)  
Net Change in Cash and Restricted Cash     106,229  
Cash and Restricted Cash - Beginning of period     546,636  
Cash and Restricted Cash - Ending of period 652,865   652,865  
Non-cash investing and financing activities:        
Change in value of common stock subject to possible redemption     3,564,178  
Waiver of deferred underwriting fee     4,025,000  
Initial classification of derivative liability in connection with issuance of convertible promissory note     275,847  
Original issue discount in connection with issuance of convertible promissory note     305,556  
Accrual of debt issue costs      
Issuance of commitment shares and leak out shares in connection with convertible promissory notes     3,952,423  
Adjustments [Member]        
Cash Flows from Operating Activities:        
Net (loss) income (1,464,897)   (4,589,897)  
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Interest income earned on investments held in Trust Account      
Stock-based compensation     2,625,000  
Amortization on debt discount     47,023  
Loss on issuance of convertible promissory notes      
Change in fair value of the derivative liability and accrued issuable equity 35,149   35,149  
Changes in operating assets and liabilities:        
Prepaid expenses      
Accounts payable and accrued expenses     1,796,879  
Net cash and restricted cash used in operating activities     (85,846)  
Cash Flows from Investing Activities:        
Cash withdrawn from Trust Account for redemptions      
Investment of cash in Trust Account      
Net cash and restricted cash provided by investing activities      
Cash Flows from Financing Activities:        
Advances from 180     (9,990)  
Proceeds from loans payable     10,000  
Repayment of advances from 180     (114,164)  
Proceeds from convertible promissory note - related party      
Repayment of convertible promissory note - related party     200,000  
Proceeds from convertible promissory notes      
Redemptions of common stock      
Net cash and restricted cash used in financing activities     85,846  
Net Change in Cash and Restricted Cash      
Cash and Restricted Cash - Beginning of period      
Cash and Restricted Cash - Ending of period    
Non-cash investing and financing activities:        
Change in value of common stock subject to possible redemption     (2,021,705)  
Waiver of deferred underwriting fee      
Initial classification of derivative liability in connection with issuance of convertible promissory note      
Original issue discount in connection with issuance of convertible promissory note      
Accrual of debt issue costs     416,692  
Issuance of commitment shares and leak out shares in connection with convertible promissory notes     $ 107,481